Co-medication and polypharmacy with ADHD medications in adults: a Swedish nationwide studyVise andre og tillknytning
2020 (engelsk)Inngår i: European Neuropsychopharmacology, ISSN 0924-977X, E-ISSN 1873-7862, Vol. 40, nr Suppl. 1, s. S28-S29Artikkel i tidsskrift, Meeting abstract (Annet vitenskapelig) Published
sted, utgiver, år, opplag, sider
Elsevier, 2020. Vol. 40, nr Suppl. 1, s. S28-S29
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-88679DOI: 10.1016/j.euroneuro.2020.09.043ISI: 000593520800037OAI: oai:DiVA.org:oru-88679DiVA, id: diva2:1520168
Konferanse
33rd Congress of the European-College-of-Neuropsychopharmacology (ECNP), Electronic Network, September 12-15, 2020
Forskningsfinansiär
Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-01172
Merknad
Funding Agencies:
European Union's Horizon 2020 research and innovation programme: Comorbid Conditions of ADHD CoCA 667302
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Mental Health (NIMH) R01MH102221
2021-01-202021-01-202021-01-20bibliografisk kontrollert